Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

TSX:ATE - Post Discussion

View:
Post by Duster340 on Jan 15, 2024 10:59am

Insider Buying

no one selling their vested rsu's but instead trading for common shares. although not a huge amount

Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 13/24 Jan 11/24 McNealey, Jennifer Direct Ownership Common Shares 57 - Exercise of rights 11,666 $1.07
Jan 13/24 Jan 11/24 McNealey, Jennifer Direct Ownership Restricted Share Units 57 - Exercise of rights -11,666 $1.07
Jan 13/24 Jan 11/24 Hoffman, Robert Direct Ownership Common Shares 57 - Exercise of rights 11,666 $1.07
Jan 13/24 Jan 11/24 Hoffman, Robert Direct Ownership Restricted Share Units 57 - Exercise of rights -11,666 $1.07
Jan 13/24 Jan 11/24 Wu, Yung Cheng Direct Ownership Common Shares 57 - Exercise of rights 13,334 $1.07
Jan 13/24 Jan 11/24 Wu, Yung Cheng Direct Ownership Restricted Share Units 57 - Exercise of rights -13,334 $1.07
Jan 13/24 Jan 11/24 Khouri, Amal Direct Ownership Common Shares 57 - Exercise of rights 40,000 $1.07
Jan 13/24 Jan 11/24 Khouri, Amal Direct Ownership Restricted Share Units 57 - Exercise of rights -40,000 $1.07
Jan 13/24 Jan 11/24 Flower, Roderick John Direct Ownership Common Shares 57 - Exercise of rights 13,334 $1.07
Jan 13/24 Jan 11/24 Flower, Roderick John Direct Ownership Restricted Share Units 57 - Exercise of rights -13,334 $1.07
Be the first to comment on this post